|

HER3 - primed Dendritic cells Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1: 1

Top Sponsors

  • H. Lee Moffitt Cancer Center and Research Institute1

Indications

  • HER2-negative Breast Cancer1
  • Triple Negative Breast Cancer1
  • Breast Cancer1
  • Cancer1

Tampa, Florida1 trial

DecipHER Trial - DC1 Tx for Early-Stage TNBC and ER Low Positive Breast Cancer

Moffitt Cancer Center

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.